Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Dimension Thera Cmn (DMTX)

1.45 -0.10 (-6.45%)

6/23/2017  4:00pm

Open:

1.55

Pre. Close:

1.55

High:

1.60

Low:

1.45

Volume:

1,177,678

Market Cap:

36.31M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.62 - 1.65

1.65 - 1.71

Low:

1.38 - 1.4

1.4 - 1.42

Close:

1.4 - 1.46

1.46 - 1.54

Technical analysis  (as of: 2017-06-23 4:33:46 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 1.87     One year: 2.18

Support:

Support1: 1.26    Support2: 1.05

Resistance:

Resistance1: 1.60    Resistance2: 1.87

Pivot:

1.26

Moving Averages:

MA(5): 1.42     MA(20): 1.22

MA(100): 1.59     MA(250): 4.28

MACD:

MACD(12,26): 0.04     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 81.82     %D(3): 81.11

RSI:

RSI(14): 60.85

52-Week:

High: 9.98  Low: 1.05  Change(%): -79.3

Average Vol(K):

3-Month: 95  10-Days 184

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
DMTX has closed below upper band by 14.7%. Bollinger Bands are 42.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to DMTX's normal range. The bands have been in this narrow range for 84 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 09 Mar 2017 23:44:04 GMT
Dimension Therapeutics' (DMTX) CEO Annalisa Jenkins on Q4 2016 Results ...

Fri, 23 Jun 2017 21:30:07 GMT
Dimension Therapeutics Inc. (DMTX) Moves Lower on Volume Spike for June 23

Wed, 10 May 2017 12:36:17 GMT
BRIEF-Dimension Therapeutics reports Q1 loss per share $0.54

Tue, 07 Feb 2017 13:01:56 GMT
Dimension Therapeutics Elects Dr. John A. Hohneker to Its Board of Directors

Tue, 31 Jan 2017 15:46:47 GMT
Cambridge gene therapy firm loses half of market cap on study results

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

25.04

Shares Float (M)

17.59

% Held by Insiders

% Held by Institutions

Shares Short (K)

467

Shares Short Prior Month (K)

335

Stock Financials

EPS

-2.120

EPS Est. Current Year

-1.750

EPS Est. Next Year

-1.800

EPS Est. Next Quarter

-0.510

Forward EPS

-1.797

Book Value (p.s.)

1.900

PEG Ratio

Profit Margin

Operating Margin

-411.69

Return on Assets (ttm)

-32.3

Return on Equity (ttm)

-73.5

Qtrly Rev. Growth

64.0

Gross Profit (p.s.)

0.458

Sales Per Share

EBITDA (p.s.)

-2.039

Qtrly Earnings Growth

Operating Cash Flow (M)

-56.53

Levered Free Cash Flow (M)

-40.27

FoxReading.com

Valuation

P/E

-0.68

P/E Growth Ratio

-0.06

P/BV

0.76

P/S

69823080.00

P/CF

-0.64

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.